We had mentioned in Wednesday’s closing report that Nifty, Sensex continue to trend up. On Thursday, the indices opened higher and closed with decent gains. On the NSE, there were 1,237 advances, 705 declines and 87 unchanged.
The trends of the major indices in the course of Thursday’s trading are given in the table below:
Infosys won a contract for digital transformation of steel maker ArcelorMittal's IT operations. Infosys will work with the London-based steel and mining firm's European arm and share its best practice to optimise, stabilise and transform its IT landscape.
Hester Biosciences has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research – Indian Veterinary Research Institute) for acquiring technologies for the production and commercialisation of classical swine fever vaccine and sheep pox vaccine.
Muthoot Finance is planning to raise Rs 1,700 crore through the public issue of secured redeemable non-convertible debentures.
Kalpataru Power Transmission’s Brazil subsidiary completed the acquisition of a 51% stake in Fasttel along with management control on 7 April 2021.
Alembic Pharma’s JV with Aleor Dermaceuticals received tentative approval from the US FDA for its new drug application for Efinaconazole Topical Solution.
Cadila Healthcare received the US drug regulator's approval for Ibrutinib capsules that are used in cancer treatment.
NBCC and Suraksha Realty have submitted fresh resolution plans for Jaypee Infratech. The Committee of Creditors (CoC) are scheduled to meet on April 12 to discuss both the resolution plans. This is the fourth time that both the companies have submitted their bids for the bankrupt company.
Bharti AXA Life Insurance has partnered with Fincare Small Finance Bank for distribution of life insurance products through the bank's pan-India network.
The top gainers and top losers of the major indices are given in the table below:
The closing values of the major Asian indices are given in the table below: